T-group (topology)
301.13.1 DAK1/DegV C-terminal domain
Ligands and drugs
254
Member domains
74
with ligand contacts (≤ 4 Å)
29.1% of members
72
with DrugDomain annotations
28.3% of members
70
with a DrugBank compound
27.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 301.13.1 belongs to X-group 301 Bacillus chorismate mutase-like, which binds 10.5 ligand superclasses per 20 proteins, broader than 97% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 22 |
| DB08231 | MYR | Myristic acid | 7 |
| DB01775 | 2HA | Dihydroxyacetone | 6 |
| DB04801 | VCA | cis-Vaccenic acid | 4 |
| DB02263 | G3H | D-glyceraldehyde 3-phosphate | 2 |
| DB02580 | PG6 | Pentaglyme | 2 |
| DB03193 | STE | Stearic acid | 2 |
| DB03756 | HXA | Doconexent | 2 |
| DB14104 | EIC | Linoleic acid | 2 |
| DB04224 | ELA | Oleic Acid | 1 |
| DB16833 | ADP | Adenosine disphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PLM | PALMITIC ACID | 22 |
| MYR | MYRISTIC ACID | 7 |
| 2HA | Dihydroxyacetone | 6 |
| NAmetal | SODIUM ION | 6 |
| OLA | OLEIC ACID | 4 |
| VCA | VACCENIC ACID | 4 |
| BMJ | (12R)-12-methyltetradecanoic acid | 2 |
| BNV | (12S)-12-methyltetradecanoic acid | 2 |
| D0G | (14S)-14-methylhexadecanoic acid | 2 |
| EIC | LINOLEIC ACID | 2 |
| G3H | GLYCERALDEHYDE-3-PHOSPHATE | 2 |
| HXA | DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID | 2 |
| PG6 | 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE | 2 |
| STE | STEARIC ACID | 2 |
| ZNmetal | ZINC ION | 2 |
| BR | BROMIDE ION | 1 |
| CL | CHLORIDE ION | 1 |
| ELA | Elaidic acid | 1 |
| P6G | HEXAETHYLENE GLYCOL | 1 |
| X90 | heptadecanoic acid | 1 |